Moleculin Biotech secures $8.3M from warrant exercises, issues new 5-year warrants
Source: SeekingAlpha
2026-02-19 08:54:28 ET
More on Moleculin Biotech
- Moleculin announces exercise of warrants for $6.8M
- Seeking Alpha’s Quant Rating on Moleculin Biotech
- Historical earnings data for Moleculin Biotech
- Financial information for Moleculin Biotech
Read the full article on Seeking Alpha
For further details see:
Moleculin Biotech secures $8.3M from warrant exercises, issues new 5-year warrants
Moleculin Biotech Inc.
NASDAQ: MBRX
MBRX Trading
-3.79% G/L:
$2.03 Last:
66,993 Volume:
$2 Open:
MBRX Latest News
February 19, 2026 08:39:00 am
Moleculin Announces Exercise of Warrants for $8.3 Million Gross Proceeds
February 18, 2026 08:20:00 am
Moleculin MIRACLE Trial Delivers 40% Preliminary Blinded CRc Rate (n=30)
February 17, 2026 08:35:00 am
Moleculin Announces Notice of Allowance for Japanese Patent Covering Annamycin
MBRX Stock Data
$11,205,089
2,639,660
N/A
11
N/A
Biotechnology & Life Sciences
Healthcare
US
Houston
